The present invention provides a quinoline base compound represented by the following general formula (1) of:
wherein X is CH2. 0 or S.
Further provided are the process for the preparation of the aforementioned quinoline base compound and an anticancer agent including the same as a pharmacologically efficacious component.
本发明提供一种
喹啉基化合物,由以下通式(1)表示: 其中X是
CH2. 0或S;进一步提供上述
喹啉基化合物的制备工艺和一种抗癌剂,包括作为药效成分的上述
喹啉基化合物。